Designed for the safety and purity you want in your treatment.

0 inhibitors were confirmed in one of the largest clinical trials programs involving previously treated patients of a rFVIII to date.a

aPeople with previous inhibitors and those new to treatment were not included in the trial. People with hemophilia A may develop inhibitors to factor VIII.

Designed for the safety and purity you want in your treatment.

0 inhibitors were confirmed in one of the largest clinical trials programs involving previously treated patients of a rFVIII to date.a

aPeople with previous inhibitors and those new to treatment were not included in the trial. People with hemophilia A may develop inhibitors to factor VIII.


Sion lives with hemophilia A.

An established safety profile.


Detergent Inactivation
Helps eliminate enveloped viruses.

Immunoaffinity Chromatography
Uniquely selects intact molecules.

Anion-exchange Chromatography
Separates molecules from impurities, based on their charge.

Double Nanofiltration
State-of-the-art double 20-nm filters remove small pathogens, reducing nonenveloped viruses.

Gel Filtration
Reduces FVIII multimers.


Recombinant manufacturing minimizes risk.

Novoeight® is produced by recombinant technology, with no animal- or human-derived components. Recombinant manufacturing minimizes the possibility of viral contamination.

What are the latest recommendations?

The National Hemophilia Foundation’s Medical and Scientific Advisory Council (MASAC) recommends recombinant products as a first-line therapy.

Patient: Rare Bleeding Disorder
MASAC Recommendation: Recombinant
Product if Available


Patient: Previously Treated Patient with Hemophilia A or B
MASAC Recommendation: Recombinant Product


Patient: Previously Untreated Patient with Hemophilia A
MASAC Recommendation: Recombinant FVlll Product or Plasma-Derived VIII Product Containing von Willebrand Factor

What if I’m new to Novoeight®?

It’s easy to get started; we’ll show you step-by-step.


Considering a switch?

It’s important to know how a treatment will fit into your life.


Product support.

Access the product support NovoSecure™ offers for qualified patients.

Selected Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery.

Novoeight® is not used to treat von Willebrand Disease.

Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII.

Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®.

Common side effects of Novoeight® include swelling or itching at the location of injection, changes in liver tests, and fever.

Please click here for Prescribing Information.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800- FDA-1088.